Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05070624
Other study ID # CTO-3590
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date September 15, 2022
Est. completion date December 30, 2024

Study information

Verified date December 2023
Source The Hospital for Sick Children
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Competent family caregivers (FC) are essential for successful caring for individuals with NMD. However, family caregiving is known to contribute to significant FC burden and social isolation, and negatively affects FC health. Infrastructure to support FCs is paramount to ensure that individuals with NMD can safely remain at home. Individuals with NMD have complex health problems, require a lot of care and they use the healthcare system often. COVID-19 physical distancing has increased the care burden and social isolation for many FCs. Infrastructure to support FCs is paramount to ensure that individuals with NMD can safely remain at home. Peer support includes emotional and informational support by an individual that has experienced a similar health problem. It improves health-related quality of life, increases self-efficacy and empowerment, and decreases stress in various patient and caregiver populations. With our study we plan to educate and empower individuals with NMD and their caregivers and develop a comprehensive peer support program.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 100
Est. completion date December 30, 2024
Est. primary completion date February 28, 2024
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Eligibility Criteria for Peer-Support Program: Inclusion Criteria 1. FC of individual with NMD that lives in Canada; 2. Speaks and reads English; 3. Access to internet and computer/tablet. Exclusion Criteria: We will exclude those Ventilator Assisted Individuals (VAI) and caregivers, who are: 1. Unable to communicate verbally in English 2. No access to internet and computer/tablet. Eligibility Criteria for Peer Mentors: Inclusion Criteria: 1. Criteria 1-3 above; 2. Completion of virtual peer support training; 3. Identified by the HMV team or self-referral. Exclusion Criteria: We will exclude those VAIs and caregivers, who are: 1. Unable to communicate verbally in English 2. No access to internet and computer/tablet.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
The Virtual Peer Support Program
Training: We have previously developed and beta-tested a virtual peer mentor training program adapted from the St. Jude's Research Hospital's (Memphis, USA) program for FCs of children with cancer for adults using HMV. Content & Design of the Virtual Peer-Support Program: The program will be delivered by the aTouchAway™ App used for the LIVE program. Participants will be requested to access peer mentors =1 time/week. Participants can choose to interact with a peer mentor which will be assigned as well as other peer participants. Onboarding: Participants and mentors will create a personal profile of their caregiving situation (e.g., duration of care, family member age and diagnosis), to enable selection of mentors by the research team believed to be well suited to address support needs, questions, and concerns based on similar lived experience.

Locations

Country Name City State
Canada The Hospital for Sick Children Toronto Ontario

Sponsors (1)

Lead Sponsor Collaborator
The Hospital for Sick Children

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Family Caregiver (FC) mastery measured using the Pearlin Mastery Scale (PMS) FC mastery measured using the Pearlin Mastery Scale (PMS) (Pearlin Mastery Scale;(scores range up to 28, higher scores = higher mastery) at baseline, baseline
Primary Family Caregiver (FC) mastery measured using the Pearlin Mastery Scale (PMS) at12 weeks (FC) mastery measured using the Pearlin Mastery Scale (PMS) at12 weeks (Pearlin Mastery Scale; (scores range up to 28, higher scores = higher mastery) 12 week
Primary Family Caregiver (FC) mastery measured using the Pearlin Mastery Scale (PMS) at 24 weeks (FC) mastery measured using the Pearlin Mastery Scale (PMS) at 24 weeks (Pearlin Mastery Scale; (scores range up to 28, higher scores = higher mastery) 24 week
Secondary Caregiver Competency - measured using the Caregiving Competence Scale Caregiver Competency - measured using the Caregiving Competence Scale, The total scores of this 4-item scale ranged from 4 to 16, with higher scores indicating higher levels of caregiving competence Baseline
Secondary Caregiver Competency - measured using the Caregiving Competence Scale Caregiver Competency - measured using the Caregiving Competence Scale, The total scores of this 4-item scale ranged from 4 to 16, with higher scores indicating higher levels of caregiving competence 12 week
Secondary Caregiver Competency - measured using the Caregiving Competence Scale Caregiver Competency - measured using the Caregiving Competence Scale, The total scores of this 4-item scale ranged from 4 to 16, with higher scores indicating higher levels of caregiving competence 24 week
Secondary Family Caregiver Burden and Stress - measured using the Zarit Burden Interview Family Caregiver Burden and Stress - measured using the Zarit Burden Interview (scores range up to 88, higher scores = higher burden) Baseline
Secondary Family Caregiver Burden and Stress - measured using the Zarit Burden Interview Family Caregiver Burden and Stress - measured using the Zarit Burden Interview scores range up to 88, higher scores = higher burden) 12 week
Secondary Family Caregiver Burden and Stress - measured using the Zarit Burden Interview Family Caregiver Burden and Stress - measured using the Zarit Burden Interview scores range up to 88, higher scores = higher burden) 24 week
Secondary Family Caregiver Depression and Anxiety: measured using the Depression and Anxiety Stress Scale Family Caregiver Depression and Anxiety: measured using the Depression and Anxiety scores range up to 42, higher scores = higher depression and Anxiety)Stress Scale Baseline
Secondary Family Caregiver Depression and Anxiety: measured using the Depression and Anxiety Stress Scale Family Caregiver Depression and Anxiety: measured using the Depression and Anxiety scores range up to 42, higher scores = higher depression and Anxiety)Stress Scale 12 week
Secondary Family Caregiver Depression and Anxiety: measured using the Depression and Anxiety Stress Scale Family Caregiver Depression and Anxiety: measured using the Depression and Anxiety scores range up to 42, higher scores = higher depression and Anxiety)Stress Scale 24 week
Secondary Family Caregiver Experience of the virtual peer support explored using qualitative interviews. Family Caregiver Experience of the virtual peer support explored using qualitative interviews. Baseline
Secondary Family Caregiver Experience of the virtual peer support explored using qualitative interviews. Family Caregiver Experience of the virtual peer support explored using qualitative interviews. 12 week
Secondary Family Caregiver Experience of the virtual peer support explored using qualitative interviews. Family Caregiver Experience of the virtual peer support explored using qualitative interviews. 24 week
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03548779 - North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2 N/A
Completed NCT04435093 - Digitalization Playful Module of Motor Function Measure Assessment for Children With Neuromuscular Disorders, MFM-Play Pilot Study.
Not yet recruiting NCT04089696 - Validation of the "ExSpiron©" in Patients With ALS N/A
Not yet recruiting NCT05785637 - Polygraphy at Home for Neuromuscular Patients Under Non-invasive Mechanical Ventilation
Completed NCT01313325 - Hippotherapy to Improve the Balance of Children With Movement Disorders N/A
Recruiting NCT04098094 - Outcomes of RV Dysfunction in Acute Exacerbation of Chronic Respiratory Diseases
Completed NCT04729920 - Home Use of Mechanical Insufflation/Exsufflation Devices in Neuromuscular Diseases
Recruiting NCT04581577 - Perceptions of the Clinical and Psychosocial Impact of Covid-19 in Patients With Neuromuscular and Neurological Disorders
Enrolling by invitation NCT05539456 - Reliability and Validity of the Turkish Version of the PedsQL 3.0 Neuromuscular Module for 2-to 4- Year-old
Completed NCT05353738 - Efficacy of Vaccination Against COVID-19 in Patients Presenting a Neuromuscular Disease With Severe Amyotrophy
Recruiting NCT04541602 - Detection of Neuromuscular Complications in Critically Ill Patients
Completed NCT03394859 - Electronic Medical Records and Genomics (eMERGE) Phase III
Enrolling by invitation NCT05099107 - Changes of Motor Function Tests in Congenital Myopathy Subjects Treated With Oral Salbutamol as Compared to no Treatment N/A
Completed NCT05070910 - NDT Effectiveness Study N/A
Recruiting NCT04100993 - Multisystem and Autonomic Complications of NMD on Long-term NIV
Not yet recruiting NCT05785546 - Elaboration of a Pronostic Score of Changes on Wheelchair's Seating System
Recruiting NCT04986059 - Effects of Pre-event Massage on Muscle Activity N/A
Completed NCT01022931 - Epidemiology and Clinical Presentation of H1N1 Infection in Children in Geneva N/A
Terminated NCT03353064 - Telemedicine for Improving Outcome in Inner City Patient Population With Hypercapneic Respiratory Failure N/A
Recruiting NCT05318638 - Soft-robotic Glove Support of High-demand Tasks N/A